Updated:
Stratford House
Stratford House, a CDC South Asia fund spin-out led by Alagappan Murugappan, provides secondary solutions for Indian private equity investors.
Stratford House
Stratford House was formed by the team that previously ran CDC Group’s South Asia fund-of-funds practice. Managing Partner Alagappan Murugappan, along with Partner Piyush Jhawar and Principal Prachi Deedwania, spent over seven years at CDC making new commitments to South Asian funds and managing a legacy portfolio spanning China and Southeast Asia. That experience gave them direct oversight of more than 60 funds and investments in over 20 fund managers — a concentrated set of relationships that became the firm’s origination engine. The firm operates as a secondary fund of funds manager, providing intermediated solutions to investors in Indian private equity. This means Stratford House buys existing LP commitments from investors seeking liquidity and sells stakes to those looking for exposure — a capital-efficient way to access the Indian market without blind-pool risk. Its strategy spans fund secondaries and GP-led transactions, with a geographic focus on India and adjacent South Asian markets. The firm advises CDC and Dayton Advisors on fund portfolio management, and its secondary partnership with Coller Capital connects it to one of the world’s largest dedicated secondaries platforms. The team’s scale is built on institutional depth rather than headcount. The firm lists four investment professionals on its website, including Singapore-based Investment Associate Wilfred Chua. While Stratford House does not disclose assets under management, its mandate from CDC — managing a portion of the legacy South Asia fund portfolio — suggests a deployment capability shaped by public-market development finance discipline. No recent operational event within the last 24 months is publicly verifiable. Stratford House’s structural differentiator is its direct lineage from a development finance institution. Unlike most secondaries managers that evolved from banking or private equity, the firm’s partners spent their formative years inside CDC’s South Asia fund team, managing a portfolio that defined the LP landscape in India. That origin gives them an information advantage on fund quality and GP behavior, and a sourcing network that blends institutional credibility with the entrepreneurial mandate of a founder-led firm.
General information
Firm type
Secondary
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
Singapore
City
Singapore
Corporate office
Singapore, Singapore
Principals
Alagappan Murugappan
Managing Partner
Piyush Jhawar
Partner
Prachi Deedwania
Principal
Sector focus
Frequently asked questions
How did Stratford House originate?
The firm was established by a spin-out from CDC Group’s South Asia Fund team. Managing Partner Alagappan Murugappan and his senior colleagues spent over seven years at CDC, where they held leadership roles in committing to South Asian funds, managing the largest portfolio of Indian funds, and overseeing legacy portfolios in China and Southeast Asia.
What does Stratford House actually do?
It provides intermediated secondary solutions in Indian private equity. That means the firm facilitates the purchase and sale of existing LP fund commitments — buying stakes from sellers seeking liquidity and placing them with buyers who want targeted India exposure. It also advises CDC and Dayton Advisors on fund portfolio management.
Is Stratford House a single-family office?
No. Stratford House is a fund of funds manager specializing in secondaries. It is not a family office and does not manage single-family wealth. Its capital solutions are directed at institutional investors and other participants in the Indian private equity industry.
Who runs investment decisions at Stratford House?
Investment decisions are led by Managing Partner Alagappan Murugappan, with Partner Piyush Jhawar and Principal Prachi Deedwania. The team collectively managed over 60 funds and invested in over 20 fund managers during their tenure at CDC, and that experience directly informs the firm’s secondary investment committee process.
What is Stratford House’s relationship with Coller Capital?
Stratford House maintains a secondary partnership with Coller Capital, one of the world’s largest dedicated secondaries investors. The nature of the partnership is not fully disclosed, but it suggests a cooperative sourcing or co-investment relationship that connects Stratford House’s India-focused deal flow with Coller’s global capital base.
Does Stratford House invest in direct deals?
No. The firm focuses exclusively on secondary transactions involving fund interests. It does not make direct investments into private companies. Its mandate is intermediated fund-of-funds activity — buying and selling LP stakes rather than originating direct equity or debt investments.
Which geographies does Stratford House cover?
The firm’s primary market is India. However, the team’s prior experience at CDC included managing fund portfolios in China and Southeast Asia, giving them a broader understanding of South and Southeast Asian private equity markets. The firm’s current disclosed activity is concentrated on Indian private equity secondaries.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: